Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance. - Wikidata - awgldk - TriplyDB

Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance.

Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance.

http://www.wikidata.org/entity/Q36404102

about

Norepinephrine and stimulant addiction The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans Cognitive enhancement as a pharmacotherapy target for stimulant addiction Competing neurobehavioral decision systems theory of cocaine addiction: From mechanisms to therapeutic opportunities.Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humans.Relationship between intranasal cocaine self-administration and subject-rated effects: predictors of cocaine taking on progressive-ratio schedules Cognitive enhancers in the treatment of substance use disorders: clinical evidence.Prefrontal cortex and drug abuse vulnerability: translation to prevention and treatment interventions.Off-label use of atomoxetine in adults: is it safe?College students' use of cocaine: results from a longitudinal study.Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance.Safety of atomoxetine in combination with intravenous cocaine in cocaine-experienced participants.Novel medications to treat addictive disorders Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.Atomoxetine attenuates dextroamphetamine effects in humans.Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.Noradrenergic modulation of cognition: therapeutic implications.Drugs currently in Phase II clinical trials for cocaine addiction.Atomoxetine in abstinent cocaine users: Sex differences.Atomoxetine in abstinent cocaine users: Cognitive, subjective and cardiovascular effects.Treatment of cocaine withdrawal anxiety with guanfacine: relationships to cocaine intake and reinstatement of cocaine seeking in rats.No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA.

P2860

Q24656833-779CC920-56A7-482D-AAB1-E68696C5EEA8 Q28240897-B49A9272-3CA1-4D53-A3B7-41ADE342F9E8 Q33599983-2A3B8330-24D1-4471-9BC4-75C867C41489 Q33865481-C0431F48-F7FB-425F-90C0-AF18E4388EF5 Q34071929-3CFBADD7-EB24-4878-8D68-6E7163D1E65B Q34106580-9CBE3126-A2BD-4BFA-91C7-F14DD7EAD978 Q34183988-5D2C73C4-9910-4748-892D-8407FD1A620E Q34424490-1697E8FD-4B07-4E80-AAB9-0454E859B1B8 Q34618993-3FCF2539-07D6-4823-BB05-2F3FE1D991A5 Q34786890-22AD239F-D188-4BF5-86E1-54263A4D8221 Q35242878-08088598-A68A-4E4B-A055-283AAA89ACC4 Q36381407-CDC889BB-8279-4E77-A8B0-FD89B1D8B70A Q37029633-220FAD4F-A34C-4FCE-9C77-7FA9899DB0D9 Q37145523-61227B23-7B48-495A-B5C8-7A854C892DB6 Q37486288-155DD81D-6185-4025-B60A-1E39B4D68C8B Q38065287-945B6BA1-6237-4351-9EDF-ECFB64286D66 Q38091914-882E9A42-CD4E-4C56-8AE6-C48A7E89CF4F Q38207705-37D40F8F-5AE5-41E3-9D85-4CCBD594CB35 Q38598616-211B7C4C-E8D5-471B-B644-CE689E79F038 Q47823644-6AE3592E-DFB5-4CA3-AF5B-A48B1DA55CAE Q48168167-0FB6282E-9C5C-4B46-8CF0-661243FFD8C7 Q48190285-7DFDB428-194C-431E-A16E-70BC990FC040

P2860

Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance.

http://www.wikidata.org/entity/Q36404102

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Safety, tolerability and subje ...... uring atomoxetine maintenance.

@ast

Safety, tolerability and subje ...... uring atomoxetine maintenance.

@en

type

label

Safety, tolerability and subje ...... uring atomoxetine maintenance.

@ast

Safety, tolerability and subje ...... uring atomoxetine maintenance.

@en

prefLabel

Safety, tolerability and subje ...... uring atomoxetine maintenance.

@ast

Safety, tolerability and subje ...... uring atomoxetine maintenance.

@en

P1433

Q36404102-FEE2E3E4-BA91-4420-B32D-B83AE79A8E54

P1476

Q36404102-129B6716-6601-4172-A56E-B9157B5AE30D

P2093

Q36404102-1F5EE47A-FE1E-4EFD-81F2-8DE7E7A6C19B

Q36404102-45701431-F2D5-4809-9C1F-F0B781AD3AD7

Q36404102-5069E9FE-2EC5-4B45-BF23-F6D1AB88D39F

Q36404102-84DAACD9-A096-4C90-9188-AAB972370E47

Q36404102-DA2457E9-9AFF-4A0E-8F38-BA7B3E73F195

P2860

Q36404102-02ED344D-1FCA-4C35-ACE0-047D8829BB4E

Q36404102-1177E2D9-F6A0-4CEE-875E-2533E43B3DF7

Q36404102-19989E8A-6A05-4E56-9B05-0C0238F0F981

Q36404102-3107ACDB-1F4C-4297-BBA4-1C78A23F65F4

Q36404102-3702F11E-4735-4D4C-BFA9-E265465FC6EF

Q36404102-371A24DE-F089-479B-9470-455EBF9337D5

Q36404102-47C88C61-7FFD-4C49-9552-C1DA3E85499A

Q36404102-4D097ED5-909B-4217-B5ED-71ECF164F4DD

Q36404102-6891A1FB-5A1F-4B85-A395-5BDBA950665F

Q36404102-74B567CD-8C9C-4A89-8E33-B89D01358C47

P304

Q36404102-386D9E39-8D36-4D1F-94EE-DD684F1BA728

P31

Q36404102-B9F21D23-0CB6-4A03-AB61-CEE58620E2BB

P356

Q36404102-24D81FC4-A34F-4481-90E6-CFF3F20157DB

P433

Q36404102-0F5AF825-7AE8-4A5B-95B3-4DF843BA7EA4

P478

Q36404102-0F64A550-F1D7-4706-8427-7AF5857D7207

P577

Q36404102-201CACC2-131A-49E3-81B9-90872E1B0483

P5875

Q36404102-CFF72F17-4D4F-4F38-9742-56D6087B00B8

P698

Q36404102-C66C1B7F-ECBA-4D2E-9D87-307723078E3D

P932

Q36404102-93249555-1117-42EB-8296-560D3DEF8B88

P356

J.DRUGALCDEP.2007.07.005

P1433

Drug and Alcohol Dependence

P1476

Safety, tolerability and subje ...... uring atomoxetine maintenance.

@en

P2093

Craig R Rush

http://www.w3.org/2001/XMLSchema#string

David A Hudson

http://www.w3.org/2001/XMLSchema#string

John W Blackburn

http://www.w3.org/2001/XMLSchema#string

Lon R Hays

http://www.w3.org/2001/XMLSchema#string

William W Stoops

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine

Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity.

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.

A double-blind, placebo-controlled trial of modafinil for cocaine dependence.

Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys.

Cardiovascular effects of atomoxetine in children, adolescents, and adults.

The pharmacology of cocaine related to its abuse.

Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans.

Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial.

An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder.

P304

282-285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUGALCDEP.2007.07.005

http://www.w3.org/2001/XMLSchema#string

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6119969

http://www.w3.org/2001/XMLSchema#string

P698

17719727

http://www.w3.org/2001/XMLSchema#string

P932

2213369

http://www.w3.org/2001/XMLSchema#string